Radiation Therapy Services Holdings, Inc. (RTSX) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

21St Century Oncology Holdings, Inc.

CIK: 1503518 Ticker: RTSX

Exhibit 99.1






Bryan J. Carey

Chief Financial Officer

(239) 931-7281


Amy Glynn / Nick Laudico

The Ruth Group

646-536-7023 / 7030




Fourth Quarter 2011 Highlights:


·                  Total company pro forma revenues grew by 23. 3% to $171.2 million

·                  Domestic same practice treatments per day increased 3.0%

·                  International treatments increased 13.6%

·                  Pro Forma Adjusted EBITDA of $28.8 million


Full Year 2011 Business Highlights


·                  Completed strategic acquisitions in Argentina, Redding, CA and Goldsboro, NC, further building market presence

·                  Obtained CONs in attractive markets of Conway, SC and Asheville, NC

·                  Increased revolver by $50 million and amended Senior Credit Facility to support continued growth

·                  Appointed Bryan J. Carey as permanent Chief Financial Officer

·                  Implemented strategies to partially offset reductions in 2012 reimbursement

·                  Pro Forma Adjusted EBITDA of $122.8 million


FORT MYERS, FL, March 7, 2012 —

Radiation Therapy Services Holdings, Inc (“the Company”), a leading operator of radiation therapy centers, today announced preliminary financial results for the fourth quarter and year ended December 31, 2011.


Dr. Daniel Dosoretz, President and Chief Executive Officer, said, “During the fourth quarter, we saw a continued trend of improving volumes, with domestic same practice treatments per day up 3.0%.  This increase reflects a continued rebound in services in some of our key markets, such as Florida and Michigan, as well as the impact of our marketing initiatives.  The 13.1% increase in same practice RVUs per day also reflects our continuing mix shift towards more clinically appropriate and sophisticated radiation oncology services.”


The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Thursday, March 8, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..


Assess how 21St Century Oncology Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: RTSX
CIK: 1503518
Form Type: 10-K Annual Report
Accession Number: 0001047469-12-003129
Submitted to the SEC: Thu Mar 22 2012 3:23:40 PM EST
Accepted by the SEC: Thu Mar 22 2012
Period: Saturday, December 31, 2011
Industry: Offices And Clinics Of Doctors Of Medicine

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: